Grantham, Mayo, Van Otterloo & Co (GMO)
DOX icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Amdocs DOX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio DOX Stock Details DOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,492
Closed -$594K – 634
2025
Q1 		$594K Sell
6,492
-7,784
-55% -$679K ﹤0.01% 530
2024
Q4 		$1.22M Buy
14,276
+4,730
+50% +$415K ﹤0.01% 417
2024
Q3 		$835K Buy
+9,546
New +$803K ﹤0.01% 463
2024
Q2 		– Sell
-8,146
Closed -$736K – 543
2024
Q1 		$736K Buy
8,146
+960
+13% +$87.5K ﹤0.01% 410
2023
Q4 		$632K Buy
+7,186
New +$599K ﹤0.01% 397
2022
Q2 		– Sell
-3,573
Closed -$294K – 764
2022
Q1 		$294K Sell
3,573
-67,968
-95% -$5.33M ﹤0.01% 646
2021
Q4 		$5.35M Buy
71,541
+6,565
+10% +$493K 0.03% 324
2021
Q3 		$4.92M Buy
64,976
+5,994
+10% +$464K 0.02% 337
2021
Q2 		$4.56M Buy
58,982
+19,416
+49% +$1.5M 0.02% 350
2021
Q1 		$2.78M Buy
39,566
+18,882
+91% +$1.43M 0.02% 426
2020
Q4 		$1.47M Hold
20,684
– – 0.01% 501
2020
Q3 		$1.19M Hold
20,684
– – 0.01% 490
2020
Q2 		$1.26M Sell
20,684
-6,500
-24% -$401K 0.01% 497
2020
Q1 		$1.49M Sell
27,184
-6,391
-19% -$428K 0.01% 441
2019
Q4 		$2.42M Sell
33,575
-5,545
-14% -$378K 0.02% 369
2019
Q3 		$2.59M Sell
39,120
-16,500
-30% -$1.06M 0.02% 383
2019
Q2 		$3.45M Sell
55,620
-10,300
-16% -$595K 0.02% 361
2019
Q1 		$3.57M Sell
65,920
-2,700
-4% -$152K 0.03% 331
2018
Q4 		$4.02M Buy
68,620
+11,700
+21% +$733K 0.03% 211
2018
Q3 		$3.76M Sell
56,920
-22,357
-28% -$1.48M 0.03% 239
2018
Q2 		$5.25M Sell
79,277
-22,978
-22% -$1.55M 0.04% 206
2018
Q1 		$6.82M Sell
102,255
-4,700
-4% -$316K 0.04% 194
2017
Q4 		$7M Sell
106,955
-46,900
-30% -$3.04M 0.04% 194
2017
Q3 		$9.9M Sell
153,855
-42,121
-21% -$2.72M 0.06% 174
2017
Q2 		$12.6M Sell
195,976
-87,100
-31% -$5.5M 0.07% 162
2017
Q1 		$17.3M Sell
283,076
-248,818
-47% -$15M 0.1% 151
2016
Q4 		$31M Sell
531,894
-256,292
-33% -$15.1M 0.17% 121
2016
Q3 		$45.6M Sell
788,186
-222,311
-22% -$13.1M 0.22% 113
2016
Q2 		$58.3M Buy
1,010,497
+570,097
+129% +$32.7M 0.24% 96
2016
Q1 		$26.6M Buy
+440,400
New +$24.7M 0.1% 166
2014
Q3 		– Sell
-57,100
Closed -$2.65M – 445
2014
Q2 		$2.65M Sell
57,100
-21,800
-28% -$1.03M 0.01% 346
2014
Q1 		$3.67M Sell
78,900
-32,448
-29% -$1.42M 0.01% 342
2013
Q4 		$4.59M Sell
111,348
-5,835
-5% -$230K 0.01% 326
2013
Q3 		$4.29M Sell
117,183
-28,121
-19% -$1.06M 0.01% 333
2013
Q2 		$5.39M Buy
+145,304
New +$5.19M 0.01% 293

Other funds holding DOX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s DOX Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Amdocs (DOX) in Q2 2025, closing a stake of 6,492 shares — an estimated $594K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DOX in Q2 2013 and held it in 35 quarters. The position peaked at $58.3M in Q2 2016. 542 funds tracked by Wall St. Rank hold DOX as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Amdocs position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 6,492 Amdocs shares in Q2 2025, an estimated $594K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Amdocs in Q2 2013 and held it in 35 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Amdocs position peaked at $58.3M in Q2 2016.
  • 542 funds tracked by Wall St. Rank held Amdocs as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.